Ketamine Ketamine
    • 11,99 €

Publisher Description

The emergence of ketamine--previously known as a combat anesthetic and club drug--as a treatment for depression.

Ketamine, approved in 2019 by the Food and Drug Administration for the treatment of depression, has been touted by scientists and media reports as something approaching a miracle cure. This volume in the MIT Press Essential Knowledge series chronicles the ascent of a drug that has been around for fifty years--in previous incarnations, a Vietnam-era combat anesthetic and a popular club drug--that has now been reinvented as a treatment for depression. Bita Moghaddam, a leading researcher in neuropharmacology, explains the scientific history and the biology of ketamine, its clinical use, and its recently discovered antidepressant effects, for the nonspecialist reader.

GENRE
Health & Well-Being
RELEASED
2021
16 February
LANGUAGE
EN
English
LENGTH
208
Pages
PUBLISHER
MIT Press
SIZE
1
MB

Other Books in This Series

Phenology Phenology
2025
Gain of Function Gain of Function
2025
Animal Rights Animal Rights
2025
Standards Standards
2025
Bilingualism Bilingualism
2025
Cryptography Cryptography
2024